Segment Analysis and Major Growth Areas in the Immunohematology Market

The immunohematology sector is poised for substantial growth as advancements in technology and diagnostics continue to evolve. With increasing integration of AI and digital systems, along with rising emphasis on precision medicine, this market is set to expand significantly by the end of the decade. Let's explore the market's valuation projections, key players, prevailing trends, and the critical segments driving this industry forward.

Projected Market Size and Growth Trajectory of the Immunohematology Market
The immunohematology market is anticipated to grow steadily, reaching a valuation of $3.27 billion by 2030. This expansion corresponds to a compound annual growth rate (CAGR) of 5.0%. The market's growth during this period is primarily fueled by advancements in analyzer technology, the increasing application of artificial intelligence in laboratory diagnostics, the rise of precision medicine, enhanced digital health system integration, and the broadening scope of blood screening programs. Key trends shaping the market include improved blood typing methodologies, greater automation in immunohematology testing, personalized transfusion therapies, point-of-care immune diagnostics, and the seamless incorporation of laboratory information systems.

Download a free sample of the immunohematology market sample:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10295&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Major Players Dominating the Immunohematology Market Landscape
The immunohematology market features several leading companies, including Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton dic*kinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Drucker Diagnostics Inc., and Immundia Diagnostics Pvt. Ltd.

Significant Acquisition Expanding Immunohematology Expertise
In March 2023, Spain-based diagnostic care firm Werfen S.A. acquired Immucor Inc., a transfusion diagnostics specialist, in a deal valued at about $2 billion. This acquisition was aimed at strengthening Werfen's portfolio in specialized diagnostic testing, particularly in delivering accessible and affordable blood testing solutions. Immucor Inc. is recognized for its focus on safe and reliable transfusion diagnostics.

View the full immunohematology market report:
https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Innovative Trends Transforming the Immunohematology Sector
Leading organizations in the immunohematology market are developing cutting-edge diagnostic tools to tackle challenges such as interference from cancer therapies. One notable innovation is the creation of soluble recombinant proteins designed to address complications caused by treatments like daratumumab. Soluble recombinant proteins are produced through recombinant DNA technology, maintaining proper folding and function in a soluble state, which makes them invaluable for both research and therapeutic purposes.

A Landmark Development in Diagnostic Solutions
For example, in November 2023, Spanish pharmaceutical company Grifols, S.A. introduced the Grifols sCD38 solution, the first soluble recombinant protein of its kind. This product was specifically developed to counteract the interference that daratumumab, a cancer therapy for multiple myeloma patients, causes during blood transfusion compatibility testing. By preventing daratumumab from binding to CD38 proteins on red blood cells, this solution ensures accurate pre-transfusion test results. The innovation helps streamline processes for blood screening, identification, and crossmatching, ultimately improving transfusion protocols and reducing delays in administering critical blood transfusions.

Detailed Segmentation of the Immunohematology Market
This report breaks down the immunohematology market into key segments for more precise analysis:
1) By Product: Analyzers and Systems, Reagents
2) By Technology: Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)
3) By Disease: Blood-Related Diseases, HIV, Hepatitis
4) By Application: Pretransfusion Testing, Investigation of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte and Platelet Serology
5) By End User: Blood Banks, Diagnostic and Reference Laboratories, Hospitals, Academic and Research Institutes

Further subcategories include:
- Analyzers and Systems: Blood Typing Analyzers, Cross-Matching Analyzers, Gel Card Systems
- Reagents: Blood Grouping Reagents, Antisera, Control Serum

This comprehensive segmentation provides a clear understanding of the various facets of the immunohematology market, highlighting the diverse technologies and applications contributing to its ongoing expansion.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.